198 related articles for article (PubMed ID: 8833963)
21. General method validation guidelines for pharmaceutical samples.
Inman EL; Frischmann JK; Jimenez PJ; Winkel GD; Persinger ML; Rutherford BS
J Chromatogr Sci; 1987 Jun; 25(6):252-6. PubMed ID: 3611281
[TBL] [Abstract][Full Text] [Related]
22. Stability studies of anticancer agent bis(4-fluorobenzyl)trisulfide and synthesis of related substances.
Bao Y; Mo X; Xu X; He Y; Xu X; An H
J Pharm Biomed Anal; 2008 Nov; 48(3):664-71. PubMed ID: 18678459
[TBL] [Abstract][Full Text] [Related]
23. Factorial designs in pharmaceutical preformulation studies. II. Studies on drug stability and compatibility in the solid state.
Ahlneck C; Waltersson JO
Acta Pharm Suec; 1986; 23(3):139-50. PubMed ID: 3766159
[No Abstract] [Full Text] [Related]
24. Application of the equivalence test for analytical method transfers: testing precision using the United States Pharmacopoeia concept (1010).
Schepers U; Wätzig H
J Pharm Biomed Anal; 2006 Apr; 41(1):290-2. PubMed ID: 16338114
[TBL] [Abstract][Full Text] [Related]
25. Tissue sample preparation in bioanalytical assays.
Smith KM; Xu Y
Bioanalysis; 2012 Mar; 4(6):741-9. PubMed ID: 22452264
[TBL] [Abstract][Full Text] [Related]
26. Precision from drug stability studies. Investigation of reliable repeatability and intermediate precision of HPLC assay procedures.
Ermer J; Arth C; De Raeve P; Dill D; Friedel HD; Höwer-Fritzen H; Kleinschmidt G; Köller G; Köppel H; Kramer M; Maegerlein M; Schepers U; Wätzig H
J Pharm Biomed Anal; 2005 Jul; 38(4):653-63. PubMed ID: 15967293
[TBL] [Abstract][Full Text] [Related]
27. [Criteria for the validation of analytical methods].
Fontani F; Prelini R; Ronchi MC; Zanotti Gerosa A
Boll Chim Farm; 1987 Feb; 126(2):66-74. PubMed ID: 3675888
[No Abstract] [Full Text] [Related]
28. Applicability of bioanalysis of multiple analytes in drug discovery and development: review of select case studies including assay development considerations.
Srinivas NR
Biomed Chromatogr; 2006 May; 20(5):383-414. PubMed ID: 16307470
[TBL] [Abstract][Full Text] [Related]
29. Impact of sample hemolysis on drug stability in regulated bioanalysis.
Bérubé ER; Taillon MP; Furtado M; Garofolo F
Bioanalysis; 2011 Sep; 3(18):2097-105. PubMed ID: 21942520
[TBL] [Abstract][Full Text] [Related]
30. Sample sizes for batch acceptance from single- and multistage designs using two-sided normal tolerance intervals with specified content.
Hauck WW; Shaikh R
J Biopharm Stat; 2001 Nov; 11(4):335-46. PubMed ID: 12018783
[TBL] [Abstract][Full Text] [Related]
31. Blood stability testing: European Bioanalysis Forum view on current challenges for regulated bioanalysis.
Freisleben A; Brudny-Klöppel M; Mulder H; de Vries R; de Zwart M; Timmerman P
Bioanalysis; 2011 Jun; 3(12):1333-6. PubMed ID: 21679027
[TBL] [Abstract][Full Text] [Related]
32. A simplified approach for the simultaneous qualification of bioanalytical methods for multiple species at late discovery stage.
Gordon J; Johnson M; Wu JT; Yu S
Bioanalysis; 2012 May; 4(9):1065-75. PubMed ID: 22612687
[TBL] [Abstract][Full Text] [Related]
33. Factorial designs in pharmaceutical preformulation studies. I. Evaluation of the application of factorial designs to a stability study of drugs in suspension form.
Waltersson JO
Acta Pharm Suec; 1986; 23(3):129-38. PubMed ID: 3766158
[No Abstract] [Full Text] [Related]
34. WHO Expert Committee on specifications for pharmaceutical preparations.
World Health Organ Tech Rep Ser; 1996; 863():1-194. PubMed ID: 8952445
[TBL] [Abstract][Full Text] [Related]
35. Bioanalytical assay validation parameters re-visited: perspectives on stability studies.
Srinivas NR
Biomed Chromatogr; 2009 Oct; 23(10):1031-3. PubMed ID: 19402178
[TBL] [Abstract][Full Text] [Related]
36. High throughput screening of protein formulation stability: practical considerations.
Capelle MA; Gurny R; Arvinte T
Eur J Pharm Biopharm; 2007 Feb; 65(2):131-48. PubMed ID: 17107777
[TBL] [Abstract][Full Text] [Related]
37. The 10th GCC Closed Forum: rejected data, GCP in bioanalysis, extract stability, BAV, processed batch acceptance, matrix stability, critical reagents, ELN and data integrity and counteracting fraud.
Cape S; Islam R; Nehls C; Allinson J; Safavi A; Bennett P; Hulse J; Beaver C; Khan M; Karnik S; Caturla MC; Lowes S; Iordachescu A; Silvestro L; Tayyem R; Shoup R; Mowery S; Keyhani A; Wakefield A; Li Y; Zimmer J; Torres J; Couerbe P; Khadang A; Bourdage J; Hughes N; Awaiye K; Matthews B; Fatmi S; Johnson R; Satterwhite C; Yu M; Lin J; Cojocaru L; Fiscella M; Thomas E; Kurylak K; Kamerud J; Lin ZJ; Garofolo W; Savoie N; Buonarati M; Boudreau N; Williard C; Liu Y; Warrino D; Kale P; Adcock N; Shekar R; O'Connor E; Ritzen H; Sanchez C; Hayes R; Bouhajib M; Savu SR; Stouffer B; Tabler E; Tu J; Briscoe C; der Strate BV; Rhyne P; Conliffe P; DuBey I; Yamashita J; Tang D; Groeber E; Vija J; Malone M; Osman M
Bioanalysis; 2017 Apr; 9(7):505-516. PubMed ID: 28339299
[TBL] [Abstract][Full Text] [Related]
38. [Analytical standards for the evaluation of biological and pharmaceutical products].
Pacheco MG
Rev Invest Salud Publica; 1970; 30(4):316-22. PubMed ID: 5516708
[No Abstract] [Full Text] [Related]
39. Applications of high-throughput ADME in drug discovery.
Kassel DB
Curr Opin Chem Biol; 2004 Jun; 8(3):339-45. PubMed ID: 15183334
[TBL] [Abstract][Full Text] [Related]
40. The sacred cow: the questionable role of assay methods in characterising the quality of bulk pharmaceuticals.
Görög S
J Pharm Biomed Anal; 2005 Jan; 36(5):931-7. PubMed ID: 15620516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
